Latest debt-to-equity ratio
Heron Therapeutics Debt-to-equity ratio
Direct answer
Heron Therapeutics's debt-to-equity ratio is 2,147.57%.
The verified market snapshot reports 2,147.57%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 27, 2026.
Get free Heron Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 2,147.57%
Explore related company data
View Heron Therapeutics's market capitalizationView Heron Therapeutics's price-to-book ratioView Heron Therapeutics's dividend yieldView Heron Therapeutics's 52-week price rangeView Heron Therapeutics's revenue growthView Heron Therapeutics's profit marginView all Heron Therapeutics key metricsReturn to Heron Therapeutics profile